Article (Scientific journals)
Prospective real-world data confirm the tolerability of cabozantinib in patients with advanced renal cell carcinoma: Interim results of the Belgian REPLICA study
Gennigens, Christine; De Ruyter, Vincent; De Sutter, David et al.
2024In European Urology Open Science
Peer Reviewed verified by ORBi
 

Files


Full Text
1-s2.0-S2666168324013296-main.pdf
Publisher postprint (72.03 kB) Creative Commons License - Attribution, Non-Commercial, No Derivative
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Gennigens, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
De Ruyter, Vincent;  Ipsen, Medical Department, Merelbeke, Belgium
De Sutter, David;  Ipsen, Medical Department, Merelbeke, Belgium
Rottey, Sylvie;  UZ Gent, Dept. of Medical Oncology, Ghent, Belgium
Language :
English
Title :
Prospective real-world data confirm the tolerability of cabozantinib in patients with advanced renal cell carcinoma: Interim results of the Belgian REPLICA study
Publication date :
2024
Journal title :
European Urology Open Science
ISSN :
2666-1683
Publisher :
Elsevier, Amsterdam, Netherlands
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 02 December 2024

Statistics


Number of views
5 (2 by ULiège)
Number of downloads
3 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi